173 related articles for article (PubMed ID: 31893469)
1. Differentiating keratoacanthoma from squamous cell carcinoma-In quest of the holy grail.
Nagarajan P
J Cutan Pathol; 2020 Apr; 47(4):418-420. PubMed ID: 31893469
[TBL] [Abstract][Full Text] [Related]
2. Plasmacytoid dendritic cells in keratoacanthoma and squamous cell carcinoma: A blinded study of CD123 as a diagnostic marker.
Fraga GR; Chow P
J Cutan Pathol; 2020 Jan; 47(1):17-21. PubMed ID: 31449667
[TBL] [Abstract][Full Text] [Related]
3. p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
Kaabipour E; Haupt HM; Stern JB; Kanetsky PA; Podolski VF; Martin AM
Arch Pathol Lab Med; 2006 Jan; 130(1):69-73. PubMed ID: 16390241
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor alpha expression helps to distinguish keratoacanthomas from squamous cell carcinomas.
Ho T; Horn T; Finzi E
Arch Dermatol; 1991 Aug; 127(8):1167-71. PubMed ID: 1863074
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic markers in the differential diagnosis of keratoacanthoma versus squamous cell carcinoma.
Fernandez-Flores A
Histopathology; 2007 Jan; 50(2):284-5. PubMed ID: 17222261
[No Abstract] [Full Text] [Related]
6. Intraepithelial elastic fibers and intracytoplasmic glycogen: diagnostic aids in differentiating keratoacanthoma from squamous cell carcinoma.
King DF; Barr RJ
J Cutan Pathol; 1980 Jun; 7(3):140-8. PubMed ID: 7440813
[TBL] [Abstract][Full Text] [Related]
7. Metastasizing keratoacanthomas? The difficulties in differentiating keratoacanthomas from squamous cell carcinomas.
Schnur PL; Bozzo P
Plast Reconstr Surg; 1978 Aug; 62(2):258-62. PubMed ID: 674415
[TBL] [Abstract][Full Text] [Related]
8. Hypertrophic lupus erythematosus: the diagnostic utility of CD123 staining.
Ko CJ; Srivastava B; Braverman I; Antaya RJ; McNiff JM
J Cutan Pathol; 2011 Nov; 38(11):889-92. PubMed ID: 21955314
[TBL] [Abstract][Full Text] [Related]
9. Lupus erythematosus mimicking mycosis fungoides: CD123
Roda Â; Travassos AR; Soares-de-Almeida L; Kutzner H
J Cutan Pathol; 2019 Feb; 46(2):167-170. PubMed ID: 30430606
[No Abstract] [Full Text] [Related]
10. Expression of keratin and involucrin in keratoacanthoma: an immunohistochemical aid to diagnosis.
Ichikawa E; Ohnishi T; Watanabe S
J Dermatol Sci; 2004 Apr; 34(2):115-7. PubMed ID: 15033195
[No Abstract] [Full Text] [Related]
11. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas.
Melendez ND; Smoller BR; Morgan M
Mod Pathol; 2003 Jan; 16(1):8-13. PubMed ID: 12527707
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin 10 and Ki-67 nuclear marker expression in keratoacanthoma and squamous cell carcinoma.
Basta-Juzbasić A; Klenkar S; Jakić-Razumović J; Pasić A; Loncarić D
Acta Dermatovenerol Croat; 2004; 12(4):251-6. PubMed ID: 15588557
[TBL] [Abstract][Full Text] [Related]
13. Expression of Cyclooxygenase-2 in Squamous Cell Carcinoma and Keratoacanthoma and its Clinical Significance.
Hua HK; Jin C; Yang LJ; Tao SQ; Zhu XH
Cell Biochem Biophys; 2015 Jun; 72(2):475-80. PubMed ID: 25575894
[TBL] [Abstract][Full Text] [Related]
14. Are keratoacanthomas really squamous cell carcinomas?
Sanders GH; Miller TA
Ann Plast Surg; 1982 Oct; 9(4):306-9. PubMed ID: 7149561
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of desmosomal glycoproteins in keratoacanthoma and squamous cell carcinoma of the skin: an immunohistochemical aid to diagnosis.
Krunic AL; Garrod DR; Smith NP; Orchard GS; Cvijetic OB
Acta Derm Venereol; 1996 Sep; 76(5):394-8. PubMed ID: 8891017
[TBL] [Abstract][Full Text] [Related]
16. Keratoacanthoma: hyperplasia, benign neoplasm, or a type of squamous cell carcinoma?
Mandrell JC; Santa Cruz D
Semin Diagn Pathol; 2009 Aug; 26(3):150-63. PubMed ID: 20043514
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma.
Kanzaki A; Kudo M; Ansai S; Peng WX; Ishino K; Yamamoto T; Wada R; Fujii T; Teduka K; Kawahara K; Kawamoto Y; Kitamura T; Kawana S; Saeki H; Naito Z
Int J Oncol; 2016 Mar; 48(3):1007-15. PubMed ID: 26782292
[TBL] [Abstract][Full Text] [Related]
18. Ki-67 may be useful in differentiating between keratoacanthoma and cutaneous squamous cell carcinoma.
Scola N; Segert HM; Stücker M; Altmeyer P; Gambichler T; Kreuter A
Clin Exp Dermatol; 2014 Mar; 39(2):216-8. PubMed ID: 24524559
[No Abstract] [Full Text] [Related]
19. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].
Corbalán-Vélez R; Martínez-Barba E; López-Poveda MJ; Vidal-Abarca Gutiérrez I; Ruíz-Maciá JA; Oviedo-Ramirez I; Martínez-Menchón T
Actas Dermosifiliogr; 2012 May; 103(4):308-16. PubMed ID: 22176864
[TBL] [Abstract][Full Text] [Related]
20. Differences in sialyl-Tn antigen expression between keratoacanthomas and cutaneous squamous cell carcinomas.
Jensen P; Clausen OP; Bryne M
J Cutan Pathol; 1999 Apr; 26(4):183-9. PubMed ID: 10335895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
